TUBERCULOSIS IN VIRGINIA

Slides:



Advertisements
Similar presentations
TB Disease and Latent TB Infection
Advertisements

Last Update: April 4, 2004 Division of Tuberculosis Control Virginia Department of Health Richmond, Virginia Tuberculosis Infection & Disease: Fundamentals.
Epidemiology of Tuberculosis in Virginia, 2004 Division of TB Control Virginia Department of Health.
Last Update: March 31, 2004 Division of Tuberculosis Control Virginia Department of Health Epidemiology of Tuberculosis in Virginia, 2002.
M. Samarkos TUBERCULOSIS IN GREECE. INTRODUCTION.
International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.
TB Outbreak in Grand Forks
TB. Areas of Concern TB cases continue to be reported in every state Drug-resistant cases reported in almost every state Estimated million persons.
Culture Conversion and Self- Administered Therapy in Privately Managed Tuberculosis Patients Melissa Ehman MPH, Jennifer Flood MD MPH, Pennan Barry MD.
Tuberculosis Infection & Disease: Fundamentals for the General Public
Figure 1. Number of Tuberculosis Cases: California, California Department of Public Health, Tuberculosis Control Branch Number of Tuberculosis.
The Changing Landscape of TB: Maryland TB in 2013 Presented by Dr. David Blythe Lisa Paulos, RN MPH, Epidemiologist Center for TB Control & Prevention.
1 Epidemiology of Pediatric Tuberculosis in the United States, 1993–2006 Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis.
Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.
TB 101 Part II Brenda Mayes, R. N. March TREATMENT TB DISEASE MDR XDR LATENT TB INFECTION.
Directly Observed Therapy  Prescribed by a physician and required by policy for all public and private patients  Strategy to ensure uninterrupted TB.
Progress of the Singapore TB Elimination Programme (STEP)
Tuberculosis in Virginia? Wendy Heirendt, MPA Public Health Advisor Division of TB Control Virginia Department of Health September 12, 2005.
V IRGINIA C OHORT D ATA – 5 YEAR TRENDS AFTER 4 YEARS OF LOCAL COHORT REVIEW Virginia achievement on National TB Indicators for the past 5 years – where.
Division of Tuberculosis Elimination Centers for Disease Control and Prevention Tuberculosis in the United States National Tuberculosis Surveillance System.
Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2011 National Center for HIV/AIDS, Viral Hepatitis, STD, and.
2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 Figure 1. Number of Tuberculosis Cases: California,
I AM NOT HOMELESS CSTE JUNE 2013 Dee Pritschet, TB Controller – North Dakota Department of Health Shawn McBride, Epidemiologist – North Dakota Department.
Surveillance Data in Action: Tuberculosis Indicators Melissa Ehman, MPH Tuberculosis Control Branch (TBCB) Division of Communicable Disease Control Center.
Tuberculosis In Texas Presentation by: Brian R. Smith, M.D., M.P.H., Regional Director.
Epidemiology of Tuberculosis in Correctional Facilities, United States, Surveillance, Epidemiology and Outbreak Investigations Branch Division.
The Epidemiology of Tuberculosis Lex Gibson, Virginia TB Program.
Number of Tuberculosis Cases: California, Number of Tuberculosis Cases.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
California Update : TB Epidemiology and Indicators CTCA October 22, 2010 Jennifer Flood MD MPH Chief, Surveillance and Epidemiology Tuberculosis Control.
More information © 2015 Denver Public Health Michelle K Haas, Kaylynn Aiona, Pete Dupree, Ellen Brilliant, Robert Belknap Improving access to Tuberculosis.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
GALVESTON COUNTY TB PROGRAM  SYED HAIDRY TB PROGRAM MANAGER  Dr. MARK GUIDRY CEO, HEALTH AUTHORITY & TB CLINICIAN.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Figure 1. Number of Tuberculosis Cases: California, Number of Tuberculosis Cases
LEARNING MODULE TITLE SUBTITLE. HISTORY OF PRESENT ILLNESS An 18 year-old woman with no past medical history and no known risks for TB presents with several.
The Epidemiology of Tuberculosis Lex Gibson, Director Virginia TB Program.
T T H H I I Tennessee Health Indicators PROGRAM DIRECTOR: DR. JON WARKENTIN DATA DIRECTOR/EPIDEMIOLOGIST: JASON CUMMINS, MPH Tuberculosis Elimination Program.
Treatment Regimens for Pulmonary Tuberculosis Caused by Drug- Susceptible Organisms Initial PhaseContinuation Phase RegimenDrugs Interval and Doses (Minimal.
TB Control Program County of San Diego County of San Diego Health and Human Services Agency Tuberculosis Control Branch Trends in Tuberculosis Highlights.
Tuberculosis in the United States
An Old Disease – New Twists A Continuing Public Health Challenge
TB Disease and Infection
The story of Munya* (and us)
TB CASE MANAGEMENT CONFERENCE
Tuberculosis for Addiction Counselors
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
Treatment of TB Disease
Tuberculosis in the United States
Tuberculosis in the United States
This is an archived document.
World Tuberculosis Day 2013
World Tuberculosis Day 2014
Treatment of Latent TB Infection (LTBI)
The Respiratory System
Tuberculosis in the United States
Epidemiology of pulmonary tuberculosis
World Tuberculosis Day 2015
اهمیت سل در چیست؟ حدود یک سوم جمعیت جهان(2 میلیارد نفر)با میکروب سل آلوده شده اند سالانه 9 میلیون نفر به سل فعال مبتلا می شوند هر ساله 1/5 تا 2 میلیون.
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
بسم الله الرحمن الرحيم.
Tuberculosis situation in the EU/EEA, 2016
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
World Tuberculosis Day 2014
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis in Wales Annual Report 2017 Data to the end of 2016
Tuberculosis situation in the EU/EEA, 2017
Presentation transcript:

TUBERCULOSIS IN VIRGINIA Wendy Heirendt, MPA Division of Tuberculosis Control Virginia Department of Health September 10, 2001

Number of Reported Tuberculosis Cases Virginia, 1910-2000 This depiction kinda resembles the topography of Virginia. The mountains are in the west and then flatten out the closer you get to the ocean.

Number of Reported TB Cases Virginia, 1995-2000

Percent of TB Cases By Age Virginia, 1995-2000 Chart 6

Percent of TB Cases By Race Virginia, 1995-2000

Percent of TB Cases By Sex Virginia, 2000 Chart 3

TB Cases By Disease Site Virginia, 1995-2000

TB Cases Diagnosed at Time of Death Virginia, 1995-2000

Percent of Foreign-born vs. US Born TB Cases Virginia, 1995-2000

Percent TB Cases with Drug Resistance* Virginia, 1994-2000 *Culture confirmed cases with drug susceptibility tests performed

Number of TB Cases* with Drug Resistance Virginia, 1994-2000 *Culture confirmed cases with drug susceptibility tests performed

Percent of Drug Resistance Among Foreign-Born & US Born Virginia, 1993-2000

Number of Reported TB/AIDS Cases Virginia, 1995-2000

Percent of TB Cases on DOT vs. Self-administered Virginia, 1995-2000

Completion of Therapy Rates Virginia, 1994-1999

VA Code 18.2-322 Anti-Spitting Law of 1906 No person shall spit, expectorate, or deposit any sputum, saliva, mucus, or any form of saliva or sputum upon the floor, stairways, or upon any part of any public building or place where the public assemble, or upon the floor of any part of any public conveyance, or upon any sidewalk abutting on any public street, alley, or lane of any town or city.

Evaluation Criteria Completion of Therapy (COT) COT in Pulmonary cases with DOT COT for LTBI by contacts Contributing or Complicating Factors Completion of treatment for cases Weight Factor: 30% Proportion of reported tuberculosis cases that complete an adequate and appropriate drug regimen within 365 days. Completion of treatment using DOT Weight Factor: 20% Proportion of pulmonary cases that receive Directly Observed Treatment (DOT) and complete therapy within 365 days. Completion of treatment for LTBI by contacts Weight Factor: 30%Proportion of contacts to known cases who complete an adequate and appropriate course of treatment for latent TB infection within 365 days. This measure does not include reactors or converters identified through other screening activities. Contributing factors Weight Factor: 20% Proportion of cases with at least one documented factor that may make the investigation more difficult or of greater public health significance. The five factors are homelessness (currently without a home or was homeless within the 12 months prior to diagnosis), HIV co-infection (as evidenced by medical documentation), drug abuse (injecting or non-injecting illicit drugs), MDR-TB (defined as resistance to INH and rifampin), and foreign birth (with arrival to the US within the last five years).

Regional Breakdown of TB Cases Virginia, 1990 and 2000

Spittoon Score by Region 2001 State North NW SW Cent East Regional Average 76 73 65 74 70 80 Winner's 100 64.9 90 83.7 86.5 North= Loudoun 100 NW= Cent Shen 64.9 SW= Roanoke 90 Cent= Henrico 83.7 East= Norfolk 86.5

COT Index by Region Virginia, 1999

Pulmonary Cases who Complete Rx with DOT Virginia, 1999

Completion of Therapy by Contacts Virginia, 1999

Proportion of Cases with Complicating Factors

The Travelling Spittoon